# Scioto Biosciences, Inc. — Form D

Scioto Biosciences, Inc. of INDIANOPOLIS, IN, a company, filed a Form D exempt-offering notice with the SEC on 2018-05-08. The offering totals $4.0M, of which $1.8M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2018-05-08
- Form: D
- Accession: 0001739633-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $1.8M
- Remaining: $2.2M
- Investors: 13
- Date of first sale: 2018-04-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-311852

## Issuer

- Name: Scioto Biosciences, Inc.
- CIK: 0001739633
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: NOYES PAVILION 5TH FLOOR E504, INDIANOPOLIS, IN, 46202
- Phone: 317-652-1840

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| James Schulz | Director | New York, NY |
| Joseph Trebley | Director | Indianapolis, IN |
| Mark Heiman | Executive Officer | Indianapolis, IN |
| Kevin Meyer | Executive Officer | Indianapolis, IN |
| James Schulz | Executive Officer | New York, NY |
| Joseph Trebley | Executive Officer | Indianapolis, IN |

## More

- [CIK 1739633 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1739633&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001739633-18-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.